GreenLight is a bio-performance company with a unique, cell-free production platform that delivers high-performing RNA solutions to human, plant, and animal challenges. GreenLight develops RNA products for plant and life science applications, and collaborates with industry leaders to advance vaccine development, pandemic preparation, crop management, and plant protection. The cutting-edge, natural platform delivers higher-quality RNA at a lower cost and higher speed than was ever before possible.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 01/09/19 | $50,000,000 | Series E |
Alexandria Venture Investments Baird Capital Blue IO Continental Grain S2G Ventures  Tao Capital Partners | undisclosed |
| 05/12/20 | $17,000,000 | Venture |
Baird Capital Flu Lab Xeraya Capital | undisclosed |
| 06/23/20 | $102,000,000 |
Baird Capital Continental Grain Cormorant Asset Management Fall Line Capital Lewis & Clark Ventures Lupa Systems MLS Capital Morningside Group S2G Ventures Tao Capital Partners | undisclosed |
